LINDSEY PLEINESS: Open Payments
NPI 1699428045 · SHELBY TOWNSHIP, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$985 in 45 payments from 15 companies in 2025. Trend: 2023 $995 · 2024 $1,333 · 2025 $985
Food & beverage: $985
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $347 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $104 |
| Novo Nordisk Inc | 5 | $95 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| Amgen Inc. | 4 | $65 |
| Exact Sciences Corporation | 2 | $49 |
| ABBVIE INC. | 2 | $49 |
| IBSA Pharma Inc. | 2 | $35 |
| Antares Pharma, Inc. | 2 | $35 |
| Aimmune Therapeutics, Inc. | 2 | $34 |
Products named: NURTEC ODT, CAPLYTA, OTEZLA, BREZTRI, Tirosint, XYOSTED, Rybelsus, UBRELVY.
Industry payments across MI — which companies pay providers there.
